NCT04282824View on ClinicalTrials.gov

Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

May 6, 2020

Study Completion Date

May 6, 2020

Conditions
Prostate Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of saliva

PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Gallium Ga 68-labeled PSMA-11

Given IV

DIETARY_SUPPLEMENT

Monosodium Glutamate

Given PO

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT04282824 - Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter